1972 related articles for article (PubMed ID: 11135170)
1. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
2. [Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts].
Otani H; Kawasaki H; Ninomiya H; Kido M; Kawaguchi H; Osako M; Kato Y; Imamura H
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):23-30. PubMed ID: 9028119
[TBL] [Abstract][Full Text] [Related]
3. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart.
Karck M; Tanaka S; Bolling SF; Simon A; Su TP; Oeltgen PR; Haverich A
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):986-92. PubMed ID: 11689805
[TBL] [Abstract][Full Text] [Related]
4. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect?
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?
Fujii M; Chambers DJ
Eur J Cardiothorac Surg; 2005 Dec; 28(6):821-31. PubMed ID: 16242951
[TBL] [Abstract][Full Text] [Related]
7. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection.
Kolocassides KG; Galiñanes M; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):623-34. PubMed ID: 9011645
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences.
Consolini AE; Ragone MI; Conforti P; Volonté MG
Can J Physiol Pharmacol; 2007 May; 85(5):483-96. PubMed ID: 17632582
[TBL] [Abstract][Full Text] [Related]
10. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of normothermic reperfusion with oxygenated potassium cardioplegia: a possible mechanism.
Yamamoto H; Magishi K; Goh K; Sasajima T; Yamamoto F
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):598-604. PubMed ID: 19584068
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning improves cardiac function after global ischemia, but not after cold cardioplegia.
Valen G; Takeshima S; Vaage J
Ann Thorac Surg; 1996 Nov; 62(5):1397-403. PubMed ID: 8893575
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning improves myocardial preservation in patients undergoing open heart operations.
Lu EX; Chen SX; Yuan MD; Hu TH; Zhou HC; Luo WJ; Li GH; Xu LM
Ann Thorac Surg; 1997 Nov; 64(5):1320-4. PubMed ID: 9386697
[TBL] [Abstract][Full Text] [Related]
14. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection.
Galiñanes M; Hearse DJ
Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
16. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
Chambers DJ; Takahashi A; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
[TBL] [Abstract][Full Text] [Related]
17. Effects of supplemental L-arginine during warm blood cardioplegia.
Hayashida N; Tomoeda H; Oda T; Tayama E; Chihara S; Akasu K; Kosuga T; Kai E; Aoyagi S
Ann Thorac Cardiovasc Surg; 2000 Feb; 6(1):27-33. PubMed ID: 10748356
[TBL] [Abstract][Full Text] [Related]
18. Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694.
Myers ML; Karmazyn M
Ann Thorac Surg; 1996 May; 61(5):1400-6. PubMed ID: 8633949
[TBL] [Abstract][Full Text] [Related]
19. Protection of the myocardium during global ischemia. Is crystalloid cardioplegia effective in the immature myocardium?
Avkiran M; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):220-8. PubMed ID: 2915557
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
Zhu B; Min S; Long C; Ye T
Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
